
17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
Author(s) -
T.A. Manuck
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/r7jq-gr22
Subject(s) - hydroxyprogesterone , obstetrics , alpha (finance) , medicine , steroid , hormone , surgery , construct validity , patient satisfaction